---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-081996"
form_type: "8-K"
ticker: "TTRX"
cik: "0002023016"
company_name: "Turn Therapeutics Inc."
filed_at: "2026-07-28T12:05:26+00:00"
generated_at: "2026-07-28T12:10:10.290193+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Turn Therapeutics releases updated investor presentation; no specific details provided

## Summary
- Filed under Item 7.01 Regulation FD; presentation dated July 28, 2026.
- Exhibit 99.1 is the investor presentation, but its content was not included in the filing text.
- No financial results, pipeline updates, or material events disclosed in the 8-K body.
- Ticker TTRX; presentation may contain corporate overview and strategy.

## SEC filing metadata
- accession: 0001213900-26-081996
- form_type: 8-K
- ticker: TTRX
- cik: 0002023016
- company_name: Turn Therapeutics Inc.
- filed_at: 2026-07-28T12:05:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023016/000121390026081996/0001213900-26-081996-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023016/000121390026081996/ea0299413-8k_turn.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-081996
- JSON: https://secwatch.observer/filing/0001213900-26-081996.json
- Plain text: https://secwatch.observer/filing/0001213900-26-081996.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.